Delivery Order SPE2DB22D3301-SPE2DB26FX4MF
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,301.55 for Lidocaine 5% Patch 30s, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under a larger contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,727.04 on August 21, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is a child contract with an ultimate completion date of August 22, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, allowing AmerisourceBergen to compete openly for this...
- The Defense Logistics Agency awarded a $17,105.21 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of July 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office as a leading pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $1,362.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count packages of Lidocaine 5% Patch on September 26, 2025, with an ultimate completion date of September 29, 2025. This non-set-aside contract was competitively awarded to support federal medical supply requirements. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $1,914.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of May 9, 2025. This non-set-aside contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The delivery order is performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $2,722.08 for Lidocaine 5% Patch 30-count units, with an ultimate completion date of August 22, 2025. This non-set-aside competitive award was issued on August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,060.56 for Lidocaine 5% Patch 30-count units on October 23, 2025, with an ultimate completion date of October 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,370.05 on August 4, 2025, for the supply of Lidocaine 5% Patch 30S, with an ultimate completion date of August 5, 2025. This non-set-aside contract utilizes firm fixed price pricing and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $14,605.17 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of October 20, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,079.33 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of October 28, 2025. This competitive award, issued on October 27, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4MFDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,664.37 for Lidocaine 5% Patch 30s, with an ultimate completion date of November 7, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The pharmaceutical product will be delivered to support federal medical supply needs, with AmerisourceBergen Drug Corp performing work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs and other federal healthcare systems, enabling the delivery of an extensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. The lidocaine patches represent a component of the pain management pharmaceuticals supplied through this strategic partnership with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 11/6/25 |